Health Care Resource Utilization, Cost and Other Outcomes of Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol First published 03/02/2022 Last updated 18/12/2025 EU PAS number:EUPAS43167 Study Finalised